Our CEO Willemijn Vader will be presenting VitroScan’s work at the Symposium: Organoids and Beyond - Next Generation In Vitro Platforms for Preclinical Drug Discovery, organized by Crown Bioscience. Willemijn will be emphasizing the added value of patient stratification using our ex vivo tumor testing platform. In addition, Willemijn will be discussing the strength of VitroScan's ex vivo 3D tumor testing platform through our most recent clinical data.
Please register here (free!) and attend the symposium from 10.00 am – 3:30 pm, December 1st, 2022 at the Rijksmuseum Boerhaave, Leiden, the Netherlands.